APC.H — Advanced Proteome Therapeutics Balance Sheet
0.000.00%
FinancialsHighly SpeculativeMicro Cap
Annual balance sheet for Advanced Proteome Therapeutics, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.136 | 0.132 | 0.002 | 0.822 | 0.544 |
| Net Total Receivables | — | — | — | 0.049 | 0.05 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.17 | 0.156 | 0.013 | 0.891 | 0.621 |
| Net Property, Plant And Equipment | 0.014 | 0.011 | 0.008 | 0.006 | 0.016 |
| Total Assets | 0.184 | 0.167 | 0.02 | 0.898 | 0.636 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.666 | 0.838 | 0.992 | 0.999 | 1.24 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | -0.373 | -0.499 | -0.269 | 1.2 | -0.432 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 0.556 | 0.666 | 0.289 | -0.302 | 1.07 |
| Total Liabilities & Shareholders' Equity | 0.184 | 0.167 | 0.02 | 0.898 | 0.636 |
| Total Common Shares Outstanding |